Search research articles
Contact Us
Filters
Showing results (361-370 of 409) with videos related to
Page
of 41
Sort By:
Journal of Clinical and Experimental Hepatology
|
December 3, 2015
Indian National Association for Study of the Liver (INASL) Guidance for Antiviral Therapy Against HCV Infection in 2015
Pankaj Puri, Anil C Anand, Vivek A Saraswat, et al.
The American Journal of Gastroenterology
|
August 10, 2023
Long-Term Treatment With Tenofovir Alafenamide for Chronic Hepatitis B Results in High Rates of Viral Suppression and Favorable Renal and Bone Safety
Henry L Y Chan, Maria Buti, Young-Suk Lim, et al.
Journal of Clinical and Experimental Hepatology
|
October 13, 2017
Corrigendum to "Indian National Association for Study of the Liver (INASL) guidance for antiviral therapy against HCV infection: Update 2016" [J. Clin. Exp. Hepatol. 6 (2016) 119-145]
Pankaj Puri, Vivek A Saraswat, Radha K Dhiman, et al.
Journal of Clinical and Experimental Hepatology
|
August 6, 2016
Indian National Association for Study of the Liver (INASL) Guidance for Antiviral Therapy Against HCV Infection: Update 2016
Pankaj Puri, Vivek A Saraswat, Radha K Dhiman, et al.
Metabolic Syndrome and Related Disorders
|
January 27, 2022
Clinicopathological Profile and Outcome of a Large Cohort of Patients with Nonalcoholic Fatty Liver Disease from South Asia: Interim Results of the Indian Consortium on Nonalcoholic Fatty Liver Disease
Ajay Duseja, Shivaram P Singh, Manu Mehta, et al.
European Radiology
|
January 20, 2021
Artificial Intelligence-assisted chest X-ray assessment scheme for COVID-19
Krithika Rangarajan, Sumanyu Muku, Amit Kumar Garg, et al.
JHEP Reports : Innovation in Hepatology
|
September 29, 2023
Tenofovir alafenamide and tenofovir disoproxil fumarate reduce incidence of hepatocellular carcinoma in patients with chronic hepatitis B
Young-Suk Lim, Henry L Y Chan, Sang Hoon Ahn, et al.
Alimentary Pharmacology & Therapeutics
|
September 27, 2024
Eight-year efficacy and safety of tenofovir alafenamide for treatment of chronic hepatitis B virus infection: Final results from two randomised phase 3 trials
Maria Buti, Young-Suk Lim, Henry Lik Yuen Chan, et al.
Journal of Clinical and Experimental Hepatology
|
May 9, 2025
Indian National Association for the Study of Liver (INASL) Guidance Statements for Determining Futility in Liver Transplantation
Anil Arora, Praveen Sharma, Ashish Kumar, et al.
Journal of Clinical and Experimental Hepatology
|
March 20, 2020
Corrigendum to "Joint Consensus Statement of the Indian National Association for Study of the Liver and Indian Radiological and Imaging Association for the Diagnosis and Imaging of Hepatocellular Carcinoma Incorporating Liver Imaging Reporting and Data System" [J Clin Expt Hepatol 9 (2019) 625-651]
Sonal Krishan, Radha K Dhiman, Navin Kalra, et al.
Page
of 41
Search research articles
Search
Showing results (361-370 of 409) with videos related to
Sort By:
Page
of 41
Journal of Clinical and Experimental Hepatology
|
December 3, 2015
Indian National Association for Study of the Liver (INASL) Guidance for Antiviral Therapy Against HCV Infection in 2015
Pankaj Puri, Anil C Anand, Vivek A Saraswat, et al.
The American Journal of Gastroenterology
|
August 10, 2023
Long-Term Treatment With Tenofovir Alafenamide for Chronic Hepatitis B Results in High Rates of Viral Suppression and Favorable Renal and Bone Safety
Henry L Y Chan, Maria Buti, Young-Suk Lim, et al.
Journal of Clinical and Experimental Hepatology
|
October 13, 2017
Corrigendum to "Indian National Association for Study of the Liver (INASL) guidance for antiviral therapy against HCV infection: Update 2016" [J. Clin. Exp. Hepatol. 6 (2016) 119-145]
Pankaj Puri, Vivek A Saraswat, Radha K Dhiman, et al.
Journal of Clinical and Experimental Hepatology
|
August 6, 2016
Indian National Association for Study of the Liver (INASL) Guidance for Antiviral Therapy Against HCV Infection: Update 2016
Pankaj Puri, Vivek A Saraswat, Radha K Dhiman, et al.
Metabolic Syndrome and Related Disorders
|
January 27, 2022
Clinicopathological Profile and Outcome of a Large Cohort of Patients with Nonalcoholic Fatty Liver Disease from South Asia: Interim Results of the Indian Consortium on Nonalcoholic Fatty Liver Disease
Ajay Duseja, Shivaram P Singh, Manu Mehta, et al.
European Radiology
|
January 20, 2021
Artificial Intelligence-assisted chest X-ray assessment scheme for COVID-19
Krithika Rangarajan, Sumanyu Muku, Amit Kumar Garg, et al.
JHEP Reports : Innovation in Hepatology
|
September 29, 2023
Tenofovir alafenamide and tenofovir disoproxil fumarate reduce incidence of hepatocellular carcinoma in patients with chronic hepatitis B
Young-Suk Lim, Henry L Y Chan, Sang Hoon Ahn, et al.
Alimentary Pharmacology & Therapeutics
|
September 27, 2024
Eight-year efficacy and safety of tenofovir alafenamide for treatment of chronic hepatitis B virus infection: Final results from two randomised phase 3 trials
Maria Buti, Young-Suk Lim, Henry Lik Yuen Chan, et al.
Journal of Clinical and Experimental Hepatology
|
May 9, 2025
Indian National Association for the Study of Liver (INASL) Guidance Statements for Determining Futility in Liver Transplantation
Anil Arora, Praveen Sharma, Ashish Kumar, et al.
Journal of Clinical and Experimental Hepatology
|
March 20, 2020
Corrigendum to "Joint Consensus Statement of the Indian National Association for Study of the Liver and Indian Radiological and Imaging Association for the Diagnosis and Imaging of Hepatocellular Carcinoma Incorporating Liver Imaging Reporting and Data System" [J Clin Expt Hepatol 9 (2019) 625-651]
Sonal Krishan, Radha K Dhiman, Navin Kalra, et al.
Page
of 41